Citation: Ma. Faris et al., TREATMENT AND PROPHYLAXIS OF DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEXIN HIV-INFECTED INDIVIDUALS, The Annals of pharmacotherapy, 32(5), 1998, pp. 564-573
Citation: P. Martineau et N. Tawil, LOW-MOLECULAR-WEIGHT HEPARINS IN THE TREATMENT OF DEEP-VEIN THROMBOSIS, The Annals of pharmacotherapy, 32(5), 1998, pp. 588
Citation: Hm. Livingston et Tm. Dellinger, INTRINSIC STAINING OF TEETH SECONDARY TO TETRACYCLINE, The Annals of pharmacotherapy, 32(5), 1998, pp. 607-607
Citation: D. Bourke et Rw. Druckenbrod, POSSIBLE ASSOCIATION BETWEEN DONEPEZIL AND WORSENING PARKINSONS-DISEASE, The Annals of pharmacotherapy, 32(5), 1998, pp. 610-611
Citation: Mk. Altundag et I. Barista, FALSE-POSITIVE URINE MELANIN PIGMENT REACTION CAUSED BY RIFAMPIN, The Annals of pharmacotherapy, 32(5), 1998, pp. 610-610
Citation: Jd. Herrington et al., LACK OF CNS PENETRATION OF DOCETAXEL IN A PATIENT WITH LEPTOMENINGEALCARCINOMATOSIS, The Annals of pharmacotherapy, 32(5), 1998, pp. 611-612
Citation: Kennie, CRITICAL ANALYSIS OF THE PHARMACEUTICAL CARE LITERATURE (VOL 32, PG 17, 1998), The Annals of pharmacotherapy, 32(5), 1998, pp. 612-613
Authors:
GIDAL BE
MALY MM
KOWALSKI JW
RUTECKI PA
PITTERLE ME
COOK DE
Citation: Be. Gidal et al., GABAPENTIN ABSORPTION - EFFECT OF MIXING WITH FOODS OF VARYING MACRONUTRIENT COMPOSITION, The Annals of pharmacotherapy, 32(4), 1998, pp. 405-409
Citation: Gd. Lamsam et Ma. Kropff, COMMUNITY PHARMACISTS ASSESSMENTS AND RECOMMENDATIONS FOR TREATMENT IN 4 CASE SCENARIOS, The Annals of pharmacotherapy, 32(4), 1998, pp. 409-416
Citation: Kw. Garey et al., AZATHIOPRINE HYPERSENSITIVITY REACTION IN A PATIENT WITH ULCERATIVE-COLITIS, The Annals of pharmacotherapy, 32(4), 1998, pp. 425-428
Citation: Vs. Bhatara et al., SEROTONIN SYNDROME INDUCED BY VENLAFAXINE AND FLUOXETINE - A CASE-STUDY IN POLYPHARMACY AND POTENTIAL PHARMACODYNAMIC AND PHARMACOKINETIC MECHANISMS, The Annals of pharmacotherapy, 32(4), 1998, pp. 432-436
Citation: Dm. Bell et al., ENDOTHELIAL DYSFUNCTION - IMPLICATIONS FOR THERAPY OF CARDIOVASCULAR-DISEASES, The Annals of pharmacotherapy, 32(4), 1998, pp. 459-470